Application of plumbagin for inhibiting growth of staphylococcus aureus biofilm

A technology of plumbagin and staphylococcus, applied in the field of biomedicine, can solve the problem that the anti-biofilm activity is seldom studied, etc.

Inactive Publication Date: 2015-05-13
JILIN UNIV
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Plumbagin is the main active ingredient of plumbagin, a common plant widely distributed in Sout

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of plumbagin for inhibiting growth of staphylococcus aureus biofilm
  • Application of plumbagin for inhibiting growth of staphylococcus aureus biofilm
  • Application of plumbagin for inhibiting growth of staphylococcus aureus biofilm

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Microdilution drug susceptibility test - Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plumbagin on suspended bacteria of Staphylococcus aureus: pick a single colony from a preserved strain of Staphylococcus aureus agar plate , inoculated in Muller-Hinton broth (MHB) medium, and cultured overnight at 37 °C with shaking. Use MHB medium to adjust the concentration of the bacterial solution so that the OD600 value is 0.4 (~5×10 8 CFU / ml), and diluted to 1×10 6 CFU / ml. Dilute the drug solution with MHB medium to make the final concentration of the drug solution 1024 μg / ml. Add 200 μl of the drug solution with a final concentration of 1024 μg / ml to the first well of each row of a sterile 96-well microtiter plate, and add 100 μl of MHB medium to the second to tenth wells. In each row, use a 100 μl pipette to remove 100 μl of liquid from the first well of each row and add it to the second well of each row for dilut...

Embodiment 2

[0021] Plate swabbing drug susceptibility test - Determination of minimum inhibitory biofilm growth concentration (MBIC) and minimum biofilm concentration (MBBC) of plumbagin on Staphylococcus aureus biofilm: solid tryptone soybean broth (TSB) culture plate Pick the single bacteria into a test tube containing 5 ml TSB, put it in a shaker at 37 °C at 180 r / min for overnight culture; take the bacterial solution and dilute it with TSB (containing 0.5% glucose) medium to an OD600 of 0.4 (equivalent to 5×10 8 CFU / ml), and further diluted to a concentration of 10 5 CFU / ml; Carefully add 200 μl of diluted bacterial solution to each well of a 96-well plate, and place it in a 37°C incubator for static culture for 24 hours. After the biofilm is formed, discard the suspension, add 250 μl PBS to each well to gently wash away the free bacteria, serially dilute the drug twice with TSB medium (0.0625-512 μg / ml) and add it to each well. DMSO content is less than 1%. Incubate at 37°C for 4...

Embodiment 3

[0024] Semi-quantitative experiment of crystal violet-the effect of plumbagin on biofilm formation ability: Staphylococcus aureus was cultured overnight in TSB medium (TSBg) containing 0.5% glucose and diluted with TSBg medium to OD600 of 0.4 (equivalent to 5×10 8 CFU / ml), and further diluted to a concentration of 10 6 CFU / ml, add 100 μl per well into a 96-well plate, dilute plumbagin 2 times, so that the final concentration is 1 / 8MIC~2MIC (0.5~8 μg / ml), and use the culture medium as a blank control. Add 100 μl to the well, and incubate at 37°C for 24 h; wash with PBS to remove planktonic bacteria, add Bouin's fixative solution to fix for 1 h; wash with PBS for 3 times, add 1% crystal violet for staining for 30 min, wash with tap water to remove floating color; Wells were dissolved with 200 μl ethanol:acetone=80:20 (v / v), and detected at a wavelength of 570nm. The test used TSB broth as a blank control, and the same test was repeated three times. Quantitative results were...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of plumbagin for inhibiting growth of a staphylococcus aureus biofilm. Under the subinhibitory concentration of 1/8 MIC (minimal inhibitory concentration)-1/2 MIC, the inhibiting effect of plumbagin on staphylococcus aureus can be ignored, PIA (polysaccharide intercellular adhesion) synthesis and extracellular DNA (eDNA) release can be inhibited, the biofilm forming is effectively inhibited, the biofilm forming capacity is reduced with increase of drug concentration, dose dependency is shown, and when the concentration of plumbagin is up to and higher than MIC, the inhibiting effect of plumbagin on the biofilm approximately tends to be stable. According to the invention, the foundation is established for research of a generation mechanism of the biofilm.

Description

technical field [0001] The invention belongs to the field of biomedicine, and specifically relates to the use of plumbagin for inhibiting the growth of Staphylococcus aureus biofilm. Background technique [0002] In recent years, with the development of medical technology, the application of artificial biomaterials is relatively extensive. At the same time, the incidence of hospital-acquired infections caused by them is also increasing, including various infections caused by various bacteria and fungi and their presence on the surface of biomaterials. Infections associated with biofilm formation. Biofilm refers to the three-dimensional complex community of bacteria formed by the adhesion and growth of microorganisms on the contact surface. At the same time, the extracellular matrix contained in the formed biofilm contains bacteria, making the microorganisms in the biofilm less susceptible to the action of antibiotics and other drugs. And the role of the human immune system,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/122A61P31/04
Inventor 郭娜赵星辰孟日增李晓旭赵梓雯于录刘宗慧
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap